Pomerantz LLP is investigating Rafael Holdings for potential securities fraud following the company's announcement that its Phase 3 drug trial for Niemann-Pick Disease Type C did not meet its primary endpoint. The trial results led to a nearly 35% drop in Rafael's stock price on September 30, 2026. The investigation aims to determine if Rafael and its executives engaged in unlawful business practices. Investors affected by the stock decline are encouraged to contact Pomerantz LLP for potential class action participation.
Regarding the investigation into Rafael Holdings, here is Pluang's snapshot of the Health sector as of Oct 28, 2026 05:02 WIB: Out of 150 priced US Health-sector stocks tradable on Pluang, 90 rose and 60 fell today. Notable movers include NVAX at USD 10.03 with a 1-day change of +6.70% and Pluang order activity showing 26% Sell / 74% Buy, SYRE at USD 98.88 up 6.43%, and MESO at USD 13.18 up 6.38%.
The global drone defense system market is projected to grow from $4.72 billion in 2025 to $18.19 billion by 2030, driven by increasing unauthorized drone incidents and demand for advanced detection and countermeasure technologies. Growth is fueled by...
Enso has expanded its real-world asset (RWA) execution infrastructure by integrating it into Robinhood Chain, an Ethereum Layer 2 network. This network is designed to support financial services and tokenized RWAs, enabling more efficient and scalable...
Liquid Network's Bitcoin reserves are nearly restored after a September exploit created unbacked tokens. The network currently holds about 3,649 BTC against 4,249 L-BTC tokens, leaving a 600 BTC shortfall. JAN3 CEO Samson Mow announced this gap will ...
Matrix secured $7.5 million in Series B funding to develop its execution layer for BNB Chain, aiming to increase transaction throughput by three to five times. The funds will support the mainnet launch, creation of a zero-knowledge validity-proof sys...
Pomerantz LLP is investigating Neogen Corporation after the FDA issued a warning about its veterinary wound care product, Neogen Vet HYCOAT, linked to at least 20 horse deaths due to contamination. The FDA called this the largest number of horse deat...
